ID   P3IP1_HUMAN             Reviewed;         263 AA.
AC   Q96FE7; B4DRR9; D1MEI0; O00318; Q49A94; Q86YW2; Q8NCJ9;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 2.
DT   07-APR-2021, entry version 153.
DE   RecName: Full=Phosphoinositide-3-kinase-interacting protein 1;
DE   AltName: Full=Kringle domain-containing protein HGFL;
DE   Flags: Precursor;
GN   Name=PIK3IP1; Synonyms=HGFL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANT SER-251.
RA   Chiang H., Chang M.;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), AND SUBCELLULAR LOCATION.
RX   PubMed=19088825;
RA   Gao P., Zeng W.T., Deng W.W., Li N., Shi T.P., Ma D.;
RT   "Both PIK3IP1 and its novel found splicing isoform, PIK3IP1-v1, are located
RT   on cell membrane and induce cell apoptosis.";
RL   Beijing Da Xue Xue Bao 40:572-577(2008).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-251.
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Mammary gland, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   SER-251.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 22-36.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally verified
RT   cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [9]
RP   GLYCOSYLATION AT SER-39 AND ASN-66, STRUCTURE OF CARBOHYDRATES, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22171320; DOI=10.1074/mcp.m111.013649;
RA   Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
RT   "Human urinary glycoproteomics; attachment site specific analysis of N- and
RT   O-linked glycosylations by CID and ECD.";
RL   Mol. Cell. Proteomics 11:1-17(2012).
CC   -!- FUNCTION: Negative regulator of hepatic phosphatidylinositol 3-kinase
CC       (PI3K) activity. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q96FE7; P43364: MAGEA11; NbExp=3; IntAct=EBI-10285708, EBI-739552;
CC       Q96FE7; O43934: MFSD11; NbExp=3; IntAct=EBI-10285708, EBI-17633886;
CC       Q96FE7; P78382: SLC35A1; NbExp=3; IntAct=EBI-10285708, EBI-12870360;
CC       Q96FE7; A2RU14: TMEM218; NbExp=3; IntAct=EBI-10285708, EBI-10173151;
CC       Q96FE7; Q9UMX0: UBQLN1; NbExp=3; IntAct=EBI-10285708, EBI-741480;
CC       Q96FE7; Q9UMX0-2: UBQLN1; NbExp=3; IntAct=EBI-10285708, EBI-10173939;
CC       Q96FE7; Q9UHD9: UBQLN2; NbExp=3; IntAct=EBI-10285708, EBI-947187;
CC       Q96FE7; O75841: UPK1B; NbExp=3; IntAct=EBI-10285708, EBI-12237619;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19088825};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:19088825}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=HGFL(L);
CC         IsoId=Q96FE7-1; Sequence=Displayed;
CC       Name=2; Synonyms=HGFL(S);
CC         IsoId=Q96FE7-2; Sequence=VSP_023639, VSP_023640;
CC       Name=3;
CC         IsoId=Q96FE7-3; Sequence=VSP_023638;
CC       Name=4;
CC         IsoId=Q96FE7-4; Sequence=VSP_043368;
CC       Name=5; Synonyms=PIK3IP1-v1;
CC         IsoId=Q96FE7-5; Sequence=VSP_053370;
CC   -!- PTM: N- and O-glycosylated. O-glycosylated with core 1 or possibly core
CC       8 glycans. N-glycan heterogeneity at Asn-66: dHex1Hex5HexNAc4 (major)
CC       and dHex1Hex6HexNAc5 (minor). {ECO:0000269|PubMed:22171320}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF528079; AAO33762.1; -; mRNA.
DR   EMBL; AF528080; AAO33763.1; -; mRNA.
DR   EMBL; GU135609; ACZ26468.1; -; mRNA.
DR   EMBL; CR456340; CAG30226.1; -; mRNA.
DR   EMBL; AK074688; BAC11140.1; -; mRNA.
DR   EMBL; AK299397; BAG61381.1; -; mRNA.
DR   EMBL; AC002073; AAB54054.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59962.1; -; Genomic_DNA.
DR   EMBL; BC011049; AAH11049.1; -; mRNA.
DR   EMBL; BC041903; AAH41903.1; -; mRNA.
DR   CCDS; CCDS13893.1; -. [Q96FE7-1]
DR   CCDS; CCDS46690.1; -. [Q96FE7-4]
DR   RefSeq; NP_001129383.1; NM_001135911.1. [Q96FE7-4]
DR   RefSeq; NP_443112.2; NM_052880.4. [Q96FE7-1]
DR   SMR; Q96FE7; -.
DR   BioGRID; 125260; 15.
DR   IntAct; Q96FE7; 7.
DR   STRING; 9606.ENSP00000215912; -.
DR   GlyConnect; 686; 11 N-Linked glycans (1 site), 5 O-Linked glycans (3 sites).
DR   GlyGen; Q96FE7; 6 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (2 sites).
DR   iPTMnet; Q96FE7; -.
DR   PhosphoSitePlus; Q96FE7; -.
DR   BioMuta; PIK3IP1; -.
DR   DMDM; 134034149; -.
DR   jPOST; Q96FE7; -.
DR   MassIVE; Q96FE7; -.
DR   PaxDb; Q96FE7; -.
DR   PeptideAtlas; Q96FE7; -.
DR   PRIDE; Q96FE7; -.
DR   ProteomicsDB; 12726; -.
DR   ProteomicsDB; 76518; -. [Q96FE7-1]
DR   ProteomicsDB; 76519; -. [Q96FE7-2]
DR   ProteomicsDB; 76520; -. [Q96FE7-3]
DR   ProteomicsDB; 76521; -. [Q96FE7-4]
DR   Antibodypedia; 1229; 130 antibodies.
DR   DNASU; 113791; -.
DR   Ensembl; ENST00000215912; ENSP00000215912; ENSG00000100100. [Q96FE7-1]
DR   Ensembl; ENST00000402249; ENSP00000385204; ENSG00000100100. [Q96FE7-2]
DR   Ensembl; ENST00000441972; ENSP00000415608; ENSG00000100100. [Q96FE7-4]
DR   GeneID; 113791; -.
DR   KEGG; hsa:113791; -.
DR   UCSC; uc003akm.4; human. [Q96FE7-1]
DR   CTD; 113791; -.
DR   DisGeNET; 113791; -.
DR   GeneCards; PIK3IP1; -.
DR   HGNC; HGNC:24942; PIK3IP1.
DR   HPA; ENSG00000100100; Tissue enhanced (blood).
DR   neXtProt; NX_Q96FE7; -.
DR   OpenTargets; ENSG00000100100; -.
DR   PharmGKB; PA162399553; -.
DR   VEuPathDB; HostDB:ENSG00000100100.12; -.
DR   eggNOG; ENOG502QTWD; Eukaryota.
DR   GeneTree; ENSGT00390000017774; -.
DR   HOGENOM; CLU_092099_0_0_1; -.
DR   InParanoid; Q96FE7; -.
DR   OMA; EQHEQKV; -.
DR   PhylomeDB; Q96FE7; -.
DR   TreeFam; TF331319; -.
DR   PathwayCommons; Q96FE7; -.
DR   SIGNOR; Q96FE7; -.
DR   BioGRID-ORCS; 113791; 10 hits in 991 CRISPR screens.
DR   ChiTaRS; PIK3IP1; human.
DR   GeneWiki; PIK3IP1; -.
DR   GenomeRNAi; 113791; -.
DR   Pharos; Q96FE7; Tbio.
DR   PRO; PR:Q96FE7; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q96FE7; protein.
DR   Bgee; ENSG00000100100; Expressed in lymph node and 229 other tissues.
DR   ExpressionAtlas; Q96FE7; baseline and differential.
DR   Genevisible; Q96FE7; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0036313; F:phosphatidylinositol 3-kinase catalytic subunit binding; IPI:UniProtKB.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0043553; P:negative regulation of phosphatidylinositol 3-kinase activity; IDA:UniProtKB.
DR   GO; GO:0014067; P:negative regulation of phosphatidylinositol 3-kinase signaling; IDA:UniProtKB.
DR   CDD; cd00108; KR; 1.
DR   Gene3D; 2.40.20.10; -; 1.
DR   InterPro; IPR000001; Kringle.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR018056; Kringle_CS.
DR   InterPro; IPR038178; Kringle_sf.
DR   Pfam; PF00051; Kringle; 1.
DR   SMART; SM00130; KR; 1.
DR   SUPFAM; SSF57440; SSF57440; 1.
DR   PROSITE; PS00021; KRINGLE_1; 1.
DR   PROSITE; PS50070; KRINGLE_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Kringle; Membrane; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000269|PubMed:15340161"
FT   CHAIN           22..263
FT                   /note="Phosphoinositide-3-kinase-interacting protein 1"
FT                   /id="PRO_0000280347"
FT   TOPO_DOM        22..168
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        169..189
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        190..261
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          24..101
FT                   /note="Kringle"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00121"
FT   CARBOHYD        39
FT                   /note="O-linked (GalNAc...) serine"
FT                   /evidence="ECO:0000269|PubMed:22171320"
FT   CARBOHYD        66
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:22171320"
FT   DISULFID        25..101
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00121"
FT   DISULFID        46..82
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00121"
FT   DISULFID        70..96
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00121"
FT   VAR_SEQ         1..157
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_023638"
FT   VAR_SEQ         24..102
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:19088825"
FT                   /id="VSP_053370"
FT   VAR_SEQ         171..263
FT                   /note="YVLGITMMVIIIAIGAGIILGYSYKRGKDLKEQHDQKVCEREMQRITLPLSA
FT                   FTNPTCEIVDEKTVVVHTSQTPVDPQEGTTPLMGQAGTPGA -> GRI (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043368"
FT   VAR_SEQ         197..234
FT                   /note="GKDLKEQHDQKVCEREMQRITLPLSAFTNPTCEIVDEK -> SVASLLGPLR
FT                   RRGGRYTKSNFVAFLPKRKQDVENQLKM (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_023639"
FT   VAR_SEQ         235..263
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_023640"
FT   VARIANT         251
FT                   /note="T -> S (in dbSNP:rs2040533)"
FT                   /evidence="ECO:0000269|PubMed:15461802,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.1"
FT                   /id="VAR_031121"
FT   CONFLICT        98
FT                   /note="D -> G (in Ref. 4; BAC11140)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        162
FT                   /note="E -> G (in Ref. 4; BAC11140)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   263 AA;  28248 MW;  197C3EEE8E54A242 CRC64;
     MLLAWVQAFL VSNMLLAEAY GSGGCFWDNG HLYREDQTSP APGLRCLNWL DAQSGLASAP
     VSGAGNHSYC RNPDEDPRGP WCYVSGEAGV PEKRPCEDLR CPETTSQALP AFTTEIQEAS
     EGPGADEVQV FAPANALPAR SEAAAVQPVI GISQRVRMNS KEKKDLGTLG YVLGITMMVI
     IIAIGAGIIL GYSYKRGKDL KEQHDQKVCE REMQRITLPL SAFTNPTCEI VDEKTVVVHT
     SQTPVDPQEG TTPLMGQAGT PGA
//
